Trump’s FDA Defends Rule to Oversee Laboratory Developed Tests

The Trump administration went to court Wednesday to defend a Biden-era FDA rule to oversee laboratory developed tests, despite earlier opposition to using that authority.

The Food and Drug Administration in an oral argument at the US District Court for the Eastern District of Texas defended the rule against a challenge from industry groups representing laboratories and scientists over whether the agency lawfully determined that it has power to regulate certain medical tests that come from a single laboratory, also known as laboratory-developed tests (LDTs).

The industry was waiting to see whether President Donald Trump would be sympathetic to their ...